Oruka Therapeutics (ORKA) Reports Positive Phase 2a Results for Psoriasis Treatment ORKA-001

On: April 30, 2026, 10:30 am EDT

URL has been copied successfully!

Share this story:

Previous Post:Fastly (FSLY), LALIGA Partner on AI-Driven Real-Time Anti-Piracy Project

Next Post:Is Spyre Therapeutics (SYRE) One of the Small-Cap Stocks That Are On Fire Right Now?